3FLI:
reference: Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR)., Flatt B, Martin R, Wang TL, Mahaney P, Murphy B, Gu XH, Foster P, Li J, Pircher P, Petrowski M, Schulman I, Westin S, Wrobel J, Yan G, Bischoff E, Daige C, Mohan R, J Med Chem. 2009 Feb 26;52(4):904-7. PMID: 19159286

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).